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S U M M A R Y
The importation of infectious diseases during a mass gathering may result in outbreaks. Infectious
diseases associated with mass gatherings vary depending on the type and location of the mass gathering.
The annual Hajj to Makkah in Saudi Arabia is one of the largest annual religious mass gatherings in the
world. Preparation for the Hajj encompasses multiple sectors to develop comprehensive plans. These
plans include risk assessment, utilizing existing medical infrastructure, developing electronic and paper-
based surveillance activity, and the use of information technology. In this review, we describe key
features of the preparedness for the 2014 Hajj and Umra, review the recent impact of emerging viruses
such as Ebola in West Africa and the Middle East respiratory syndrome coronavirus (MERS-CoV) in
affected countries, and highlight the updated requirements and the required vaccines.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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A mass gathering is deﬁned as a group of more than 1000 people
present in one location; however, most of the published literature
reﬂects much larger congregations (>25 000 people).1 A more
inclusive deﬁnition is a large number of people attending an event
that is focused at speciﬁc sites for a ﬁnite time.2–4 The World
Health Organization (WHO) deﬁnition is ‘‘events attended by a
sufﬁcient number of people to strain the planning and response
resources of a community, state or nation’’.5
Mass gatherings can be classiﬁed into two types: spontaneous
gatherings (e.g., the Pope’s funeral) and planned gatherings.
Planned gatherings may be recurrent at different locations (e.g.,
Olympics and World Cup) or recurrent events at the same location
(e.g., Hajj pilgrimage in Saudi Arabia). The numerous examples of
mass gathering events and the number of attendees have been
reviewed.6
One of the major concerns regarding mass gatherings is the
importation of infectious diseases resulting in outbreaks, or the
exportation thereof, especially at events drawing visitors from
different nations, regions, and cultures.7 Infectious diseases* Corresponding author. Tel.: +966 505483515.
E-mail address: zmemish@yahoo.com (Z.A. Memish).
http://dx.doi.org/10.1016/j.ijid.2014.07.001
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).associated with mass gatherings vary depending on the type
and location of the mass gathering.8 For example, religious
gatherings are usually associated with respiratory and gastroin-
testinal diseases.
The annual Hajj to Makkah in Saudi Arabia is considered one of
the largest annually recurring religious mass gatherings in the
world. The number of pilgrims attending the annual Hajj or Umra
each year is about 10 million, and these pilgrims originate from
184 countries.9 The annual number of pilgrims increased from
58 584 in 1920 to 3 161 573 in 2012.10 The annual Hajj is an
excellent example for a discussion on the public health preparation
from a mass gathering medicine perspective. Thus, in this review
we present an overview of the preparation for the Hajj as an
example of a mass gathering. Further, we discuss the methodology
for surveillance and the control measures for infectious diseases.
Given the importance of Middle East respiratory syndrome (MERS)
at recent and upcoming Hajj gatherings, we also provide an
overview of Middle East respiratory syndrome coronavirus (MERS-
CoV) preparedness.
2. Preparations for mass gatherings and public health
interventions
There are three core areas that should be considered for mass
gathering preparedness: risk assessment for what might happen,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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response when there is a disease outbreak.1
During the Hajj, public health efforts take place to maintain the
highest level of excellence and these efforts are coordinated by 24
committees.9–11 Regarding the Hajj, and based on the US Centers
for Disease Control and Prevention (CDC) Risk Assessment
Framework for the Severity and Probability Analysis,8 the
preventive program framework consists of many players who
are involved from the beginning in the preparation and risk
assessment (Figure 1).
The Supreme Hajj Committee is charged with coordinating and
developing the annual Hajj plan and all studies, and in formulating
the recommendations for developing Hajj facilities. The Hajj
Preventive Medicine Committee is responsible for public health
and preventive matters during the Hajj.12 The Committee is also
responsible for the control of ports of entry for all pilgrims and
conﬁrms compliance with Hajj requirements.13 In addition, input
regarding outbreak management and emerging diseases is
received from the WHO, European Centre for Disease Prevention
and Control (ECDC), Public Health England (PHE), and the CDC,
through the Public Health Directorate of the Ministry of Health of
the Kingdom of Saudi Arabia (KSA MoH) (Figure 2).
3. Medical infrastructure, surveillance activity during Hajj, and
use of information technology
During the Hajj, surveillance depends on both electronic and
paper systems (Table 1).
Information technology (IT) is used for public health surveil-
lance during the Hajj. IT plays an essential and important role in
the success of the pilgrimage season in many ways, most notably
by providing a robust medium that transfers and analyzes data in a
timely manner to prepare accurate statistics, which facilitates
appropriate decision-making. A centralized and dedicated data
center was built to eliminate the process of connecting to different
sites in order to obtain the data needed for the Hajj operation team.Figure 1. Structure of the Saudi committees for the Hajj from the local Makkah region to t
and risk assessment of each Hajj season.The ﬁrst step in gathering and sending data to the Hajj operation
team at the command center involves the end-user stations.
Therefore, major local area network (LAN) projects were imple-
mented to connect all end-user stations with both wired and
wireless connections to the data center. These projects included all
the hospitals and medical centers at the Holy sites (Mena, Arafat,
and Mozdalefah). Due to constant connectivity problems related to
the service provider, a major wireless wide area network project
was started in 2011 to cover all participating hospitals, medical
centers, and directorates in both Makkah and Madina cities. The
new network is owned by the Ministry of Health and has various
connection speeds – starting from 54 MB and going up to 1.2 GB –
depending on each site’s criticality and workload.
In the past, raw data were gathered and submitted to the
statistics team in the form of printed papers and the team had to
perform the analysis manually. Nowadays, following the imple-
mentation of the business intelligence (BI) system, the data are
gathered automatically and the BI system performs all the analyses
required, presenting the end result statistics in the form of
dashboards displayed on a video wall and interactive board for the
Hajj operation team at the command center.
Hospitals at Holy sites previously lacked a uniﬁed system to
gather patient-related data and depended heavily on manual
efforts to gather the data required. The Hajj System was built to
address this issue and provides a computer-based entry for all data,
thus eliminating any delay and human error in gathering and
sending the necessary data. The system is web-based with
multisite capabilities and was implemented in Mena Emergency
Hospital this year and will be rolled out to the other seven hospitals
by next year.
The Healthcare Electronic Surveillance Network (HESN) is a
web-based electronic health solution that is being implemented in
KSA. HESN is the KSA MoH conﬁgured system of the Public
Health Solution for Disease Surveillance and Management,
which is organized into seven major components: communicable
disease case management, outbreak management, immunizationhe Supreme Hajj Committee. These different committees coordinate the preparation
Figure 2. Structure and coordination for Hajj plan, where input regarding outbreak management and emerging diseases is received from different organizations such as the
World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Public Health England (PHE), and the United States Centers for Disease
Control and Prevention (CDC) through the Public Health Directorate of the Kingdom of Saudi Arabia Ministry of Health. CTHMIHR refers to Custodian of the Two Holy Mosques
















Figure 3. An example of data produced using digital pens to monitor the categories
of diagnoses of patients visiting primary care clinics during the 2013 Hajj season.
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ment, notiﬁcations management, work management, and the
National Health Safety Network (NHSN). To simplify data
gathering at the primary medical center, the use of digital pens
was implemented in 2012 for the transformation of conventional
forms into digital forms that provide demographic and medical
data in a timely fashion. The system was enhanced in 2013, adding
dressing and observation forms, and was also implemented in the
outpatient departments of two hospitals (Mena Emergency
Hospital and Jabil Arrahma Hospital). Figure 3 depicts an example
of the data produced using digital pens to monitor the categories of
diagnoses for patients visiting primary care clinics during the Hajj.
Database-level integration with both statistics and the Hajj System
was achieved and data smoothly transferred from the digital pen
system to the other two systems. It is important to note that 1000
forms can be loaded electronically. Thus, it is easy to capture the
different diagnoses of patients attending the clinics and to display
this in a graph. Table 1






1 Novel coronavirus Yes Yes
2 Meningococcal meningitis Yes Yes
3 Viral hemorrhagic fever
(Ebola Virus Disease, Rift Valley fever,
dengue fever, Crimean-Congo hemorrhagic
fever and others)
Yes Yes
4 Plague Yes Yes
5 Yellow fever Yes Yes
6 Cholera Yes Yes
7 Food-borne illness Yes Yes
8 Polio Yes Yes
9 Inﬂuenza-like illness Yes -The ambulance information system (AIS) saves all medical and
administrative procedures performed for the patient in the
ambulance and sends the data – via the Internet – to the
responsible parties in the emergency room (ER) of the destination
hospital. Automatic vehicle location (AVL) techniques have the
potential to improve urban vehicle ﬂeet operations.10 The main
purpose of this project has been to identify the location of
ambulances and guide them via a map with live trafﬁc densities. In
addition, the technology allows the tracking of each ambulance’s
status – moving, idle or off, speed, etc.
4. Methodology of Hajj surveillance — the example
of MERS-CoV
Surveillance during the Hajj is a case-based surveillance. Data
are collected from all hospitals located in the Hajj area. For
example, during the 2012 Hajj season and due to the emergence of
MERS-CoV a few weeks before the Hajj,14 the KSA MoH utilized the
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following: to monitor MERS-CoV closely during this mass
gathering event, to detect any cases among pilgrims and local
residents in a timely manner, and to collect information about the
virus in the area in which the ﬁrst case was located if this were to
occur. Clinical samples were taken from all suspected cases during
2013 Hajj season and tested for all possible viral etiologies
including MERS-CoV; all samples tested negative for MERS-CoV.15
In addition, following the 2013 Hajj, a cohort of 129 French Hajj
pilgrims were systematically sampled with nasal swabs prior to
returning to France and were screened for MERS-CoV. The majority
of them (90.7%) had respiratory symptoms and none tested
positive for MERS-CoV.16
Respiratory illnesses are common among pilgrims. The most
common viral respiratory tract infections are inﬂuenza and
rhinovirus.17 The estimated incidence of upper respiratory tract
infections (URTIs) during the Hajj ranges from 20% to 80%,
depending on the type of method used to conﬁrm the diagnosis.15
During the 2009 Hajj season, the emergence of pandemic H1N1
was of great concern. There was no increased risk of this virus
during the Hajj season.17 A cohort survey was conducted in
collaboration between France and Saudi Arabia during the Hajj
2012.18,19 Participants were followed up and sampled before
departing from France to the KSA, during their pilgrimage in the
KSA, and just before leaving the KSA.18,19 Nasal swabs were
collected from participants and tested for 11 respiratory viruses
and four bacteria by real-time reverse transcription PCR. Of 165
participants who had nasal swabs collected before departing to the
KSA, eight (4.8%) were positive for one virus or more, including
rhinovirus, inﬂuenza virus, adenovirus, and enterovirus, and 7.3%
had Streptococcus pneumoniae.18,19 Among symptomatic pilgrims,
27 (38.6%) were positive for one or more viruses.18 The rate of
S. pneumoniae carriage was 7.1% in the country of origin and 19.5%
before departing from the KSA.19 These data indicate the risk of
acquiring respiratory tract infections during the Hajj and the
potential for the spread of the acquired organisms upon returning
home.18,19
5. Infection control for the Hajj in the healthcare setting
Each year the KSA MoH provides the required supplies for
proper infection control measures in the healthcare settings of the
Hajj cities. These supplies include substances for hand disinfection,
surgical tool sterilization, and hospital disinfection.20 Many years
ago, due to the need to isolate patients with infectious diseases,
mobile isolation devices were provided for installation during the
pilgrimage season.20 In a study that evaluated the annual infection
control practices in all KSA MoH hospitals in the Holy City of
Makkah from 2003 to 2006, there was a signiﬁcant increase in the
average scores of hospitals in 11 infection control items, from 43%
(20–67%) in the ﬁrst audit to 78% (61–93%) in the fourth audit.21 A
survey of 392 healthcare workers working in hospitals during the
2003 Hajj season showed that 81.8% correctly answered at least
ﬁve of the 11 knowledge statements.22
6. Infection control in camps during the care of Pilgrims with
respiratory symptoms
For the prevention of respiratory tract infections among
pilgrims it is important to observe personal hygiene, cough
etiquette, and hand hygiene. In a cohort of 274 French pilgrims in
2009, 77.4% used hand disinfectant, 89.8% used disposable
handkerchiefs, and 79.6% used face masks; 97.4% were vaccinated
against seasonal inﬂuenza, 5.8% against inﬂuenza H1N1, and 31.4%
against pneumococcus.23It is thought that the use of masks may reduce exposure to
droplet nuclei and thus decrease respiratory tract infections.17 The
use of a facemask was signiﬁcantly higher during the 2009
inﬂuenza A H1N1 outbreak (8.4%) than during the 2013 MERS-CoV
outbreak (0.02%).24 A recent review of the effectiveness of the
facemask in the prevention of respiratory infections among
pilgrims revealed variable results.25
The practice of social distancing, hand hygiene, and contact
avoidance has been associated with a reduced risk of respiratory
illness.17 Following the recommended vaccines would decrease
the risk of acquiring respiratory tract infections.17,26,27 In a recent
study, 65 vaccinated Hajj pilgrims and 41 controls were studied
and there was no signiﬁcant difference in the pattern of occurrence
of symptoms of respiratory illness by duration of pilgrimage or the
number of symptoms between the two groups.28
7. Vaccine recommendations
The vaccinations required for the 2014 Hajj and Umra seasons
have been issued by the KSA MoH.29 These recommendations
include immunization against yellow fever, poliomyelitis, and
meningococcal meningitis (Table 2).
The yellow fever vaccination is required for travelers coming
from yellow fever endemic countries in Africa and South America.
A certiﬁcate of valid yellow fever vaccination showing vaccination
at least 10 days prior to arrival is required. Pilgrims coming from
these countries with no proof of vaccination are monitored for 6
days from the last date of potential exposure to yellow fever
infection.29 The yellow fever vaccination is said to be valid for 10
years. However, at the WHO World Health Assembly in May 2014
an amendment was adopted, stipulating that the validity of the
certiﬁcate be changed from 10 years to the duration of the life of
the person vaccinated.30
The meningococcal meningitis vaccine is required for all
pilgrims and they should show proof of vaccination with the
quadrivalent (ACYW135) meningococcal vaccine received not less
than 10 days and not more than 3 years previously.29 In addition to
this requirement, pilgrims from the African meningitis belt will
receive ciproﬂoxacin 500 mg as chemoprophylaxis at the port of
entry.29
On May 5, 2014, the Director-General of the WHO declared the
international spread of wild poliovirus (WPV) to be a public health
emergency of international concern (PHEIC).31,32 Pilgrims arriving
from countries where poliomyelitis is established, has become
reestablished, or is being exported should receive an oral or an
inactivated polio vaccine (OPV or IPV) 4 weeks to 12 months before
travel.12,32 In addition, these pilgrims will receive one dose of OPV
on arrival in to KSA.12,32
8. Travel advice on MERS-CoV for 2014 Hajj pilgrimages
At the time of the initial emergence of MERS-CoV in 2012, there
was no restriction on travel or performance of Hajj or Umra due to
the limited number of human cases.14,33 The recommendations
included that pilgrims practice proper hand hygiene and apply
protective behaviors and cough etiquette.14,17,33,34 The practice of
hand hygiene and cough etiquette resulted in less respiratory
illness among United States travelers to the 2009 Hajj.35 In
addition, in 2013 the KSA MoH recommended that people aged
over 65 years, those with chronic diseases (e.g., heart disease,
kidney disease, respiratory disease, diabetes) and pilgrims with an
immune deﬁciency (congenital or acquired), malignancy, or
terminal illness, pregnant women, and children aged under
12 years postpone the performance of the Hajj and Umra for
their own safety, as well avoiding unnecessary contact with farm,
Table 2
Health requirements and recommendations for entry visas for the Hajj and Umra seasons in 2014a
Countries or areas at risk Requirement
Yellow fever Africa: Angola, Benin, Burkina Faso, Burundi, Cameroon, Central
African Republic, Chad, Congo, Cote d’Ivoire, Democratic
Republic of the Congo, Equatorial Guinea, Ethiopia, Gabon,
Guinea, Guinea-Bissau, Gambia, Ghana, Kenya, Liberia, Mali,
Mauritania, Niger, Nigeria, Rwanda, Senegal, Sierra Leone,
Sudan, South Sudan, Togo, and Uganda
South and Central America: Argentina, Venezuela, Brazil,
Colombia, Ecuador, French Guiana, Guyana, Panama, Paraguay,
Peru, Bolivia, Suriname, and Trinidad and Tobago
A valid yellow fever vaccination certiﬁcate (10 days prior to
arrival). In the absence of such a certiﬁcate, the individual will
be placed under strict surveillance for 6 days from the last date
of potential exposure to infection
Meningococcal meningitis (a) Visitors from all countries (a) Certiﬁcate of vaccination with the quadrivalent (ACYW135)
vaccine issued not more than 3 years previously and not less
than 10 days before arrival in Saudi Arabia
(b) Visitors from the African meningitis belt: Benin, Burkina
Faso, Cameroon, Chad, Central African Republic, Coˆte d’Ivoire,
Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Mali, Niger,
Nigeria, Senegal, and Sudan
(b) ACYW135 vaccine (as above) AND ciproﬂoxacin 500 mg
chemoprophylaxis will be administered at the port of entry
(c) Interior pilgrims and Hajj workers (c) Vaccination with quadrivalent (ACYW135) vaccine is
required for:
 All citizens and residents of Madina and Makkah (not
vaccinated during the past 3 years)
 All citizens and residents undertaking the Hajj
 All Hajj workers (not vaccinated in the past 3 years)
 Any individual working at entry points or in direct contact
with pilgrims in Saudi Arabia
Poliomyelitis (a) Polio-affected countries and reestablished transmission
countries: Pakistan, Equatorial Guinea, Ethiopia, Iraq, Nigeria,
Somalia
(b) Exporting countries (currently exporting wild poliovirus):
Cameroon, Pakistan, Syria
(c) Countries with unknown vaccination coverage: Yemen
Should ensure that all residents and long-term visitors (of over
4 weeks) receive an oral polio vaccine (OPV) or an inactivated
poliovirus vaccine (IPV) 4 weeks to 12 months before
international travel and should ensure that such travelers are
provided with proof of vaccination AND all will receive one dose
of OPV at the border on arrival to Saudi Arabia
Seasonal inﬂuenza All The Ministry of Health of Saudi Arabia recommends that all
pilgrims be vaccinated against seasonal inﬂuenza
a This is an updated version of a table published in the following article: Al-Tawﬁq JA, Memish ZA. The Hajj: updated health hazards and current recommendations for 2012.
Euro Surveill 2012;17. pii: 20295. Available online at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20295 (with permission).
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place for 2014.10,36
The WHO recently endorsed the KSA MoH recommendations
for MERS-CoV prevention and stressed that its member states use
all practical and effective means of communication possible to
communicate information on a range of issues before, during, and
after Umra and Hajj to all key groups, including travelers to Umra
and Hajj, and particularly, vulnerable groups within this popula-
tion. In addition, member states should support the efforts of the
KSA MoH in making health-related advice available to all travelers
departing for Umra or Hajj by working with the travel and tourism
sectors and placing such materials at strategic locations. Various
strategies for the communication of the health recommendations
should be utilized, including pamphlets and radio and television
programs.37 In their guidance to countries, the WHO stressed the
enforcement of the recommendation that pilgrims who develop a
signiﬁcant acute respiratory illness with fever and cough (severe
enough to interfere with usual daily activities) during Umra or Hajj,
or after return to their country of origin, should report to the
medical health facility closest to them and cover their mouth and
nose when coughing or sneezing and wash hands afterwards, or if
this is not possible, cough or sneeze into the upper sleeves of their
clothing; further they should avoid attending crowded places and
preferably isolate themselves until the end of the respiratory
symptoms and, if isolation is not possible, use a tissue to cover the
nose and mouth or a surgical mask when in crowded places.
9. Hajj-related advice regarding other emerging infectious
diseases
In the event of a PHEIC, or in the case of any disease outbreak
subject to notiﬁcation under the International Health Regulations2005, the health authorities in Saudi Arabia usually undertake
additional preventive precautions following consultation with the
national communicable diseases committees and on receiving the
necessary governmental approval to avoid the spread of infection
during the pilgrimage or on return to the country of origin. This has
been applied to Ebola this year, with a restriction on pilgrims from
countries where outbreaks of Ebola are ongoing, such as Guinea,
Liberia, and Sierra Leone. The current outbreak was initially
reported from Guinea, including the capital city of Conakry, and
then in March 30, 2014, cases were reported in the district of Foya
in neighboring Liberia; in May 2014, the ﬁrst cases were identiﬁed
in Sierra Leone.38 On August 8, 2014 the World Health Organiza-
tion declared that the epidemic of ebola to be a Public Health
Emergency of International Concern (PHEIC). In addition, the
recent polio outbreak in Pakistan and Syria and the WHO
International Health Regulation Emergency Committee recom-
mendations have been enforced. Recently, Brazil was exposed to a
poliovirus importation with no evidence of transmission and thus
no additional measures were needed for travelers.39
10. Conclusions
Mass gatherings in general and the Hajj in particular continue to
grow in number and magnitude. It is crucial that knowledge and
experiences are shared and evaluated. It is important to turn mass
gathering health into a proper scientiﬁc discipline and to create a
global mass gathering network to serve as a platform for the
exchange of learning and experience. It is important to update the
immunization status of pilgrims against vaccine-preventable
diseases. Preparation for international travel and for the Hajj in
particular is an excellent opportunity to review the immunization
status of travelers. It is important to keep in mind the vaccinations
J.A. Al-Tawﬁq, Z.A. Memish / International Journal of Infectious Diseases 27 (2014) 26–31 31required for attendance at the Hajj (e.g., meningococcal vaccina-
tion and polio vaccination).
Conﬂict of interest: The authors have no conﬂicts of interest; the
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